Overview
Cell and gene therapies are regulated in Saudi Arabia as advanced therapy medicinal products (ATMP). We support developers with SFDA regulatory strategy, submissions and local representation.
Expertise
SFDA strategy, submissions and local representation for advanced therapies.

Overview
Cell and gene therapies are regulated in Saudi Arabia as advanced therapy medicinal products (ATMP). We support developers with SFDA regulatory strategy, submissions and local representation.
Services
Insights
ArticlesBiotechnology in Saudi Arabia & GCC Countries: A Health Security and Economic Diversification
NewsPharmaKnowl Connects with Global Biopharma Leaders at BIOCHINA 2026
ArticlesHow SFDA Classifies and Regulates Combination Products in Saudi Arabia
ArticlesSFDA Designations and Accelerated Pathways
ArticlesWhat are the eCTD Requirements in SFDA?
ArticlesExplore the SFDA Conditional Approval AdvantageResources
Contact our team
Schedule a call or request a tailored proposal from our team.